TKTL1 and prostate cancer: Furthermore, the sensitivity and specificity of the combined detection of serum Apo10 and TKTL1 levels in distinguishing oral squamous cell carcinoma patients, prostate cancer patients, and healthy controls were 95.8% and 97.3%, respectively.